课题基金 / 基金详情

Mechanistic investigation for neutralization of toxic heme by histidine rich protein (HRP2) of malaria parasite using a series of HRP2 model peptides

Mechanistic investigation for neutralization of toxic heme by histidine rich protein (HRP2) of malaria parasite using a series of HRP2 model peptides
使用一系列 HRP2 模型肽研究疟原虫富含组氨酸的蛋白 (HRP2) 中和有毒血红素的机制
批准号:
15550146
负责人:
TAJIMA Kunihiko
金额:
$2.43万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

TAJIMA Kunihiko的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A series of model peptides, 9 to 27-mer, of Plasmodium Falciparum histidine rich protein 2(HRP2). The coordination reactions occurring between these peptides and ferric iron complex of meso-porphyrin (Fe(III)MP) were studied by using optical absorption measurements and electron spin resonance spectroscopy at 4.2 K. Based on the optical spectrometric titration, the dissociation constants for the heme-peptide complexes were evaluated. The longest peptide 27-R (three repeat of reciprocal sequence of HRP2 ; Ala-His-His-Ala-His-His-Ala-Ala-Asp), Ala-His-His-Ala-His-His-Ala-Ala-Asp-His-His-Ala-His-His-Ala-His-His-Ala-Ala-Asp-Ala-His-His-Ala-His-His-Ala-Ala-Asp, showed significantly high Kd value as 0.97 μM, which correspond to that of naturally occurring HRP2 (0.77 μM). The Kd values of the peptides revealed concomitant decrease with decrease of the number of His residue, for example, the Kd value of the shortest prptide 10R (Ala-His-His-Ala-Ala-Asp-Ala-His-His-Ala) was evaluated to be 77 mM. The both 27R- and 10R-Fe(III)MP complexes gave an identical absorption maxima (405, 533, and 564 nm) ascribed to be the six coordinate iron porphyrin complex. Taking into account the results of ESR spectroscopy, the both axial ligands of these complexes were identified to be nitrogen atoms of imidazole moiety of His.
期刊论文(36)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1021/bi048034x
发表时间: 2005-02-22
期刊: BIOCHEMISTRY
影响因子: 2.9
作者: [Kanaori, K, Kamei, K, Hara, S]
通讯作者: Hara, S
Tajima, M.: "Nitration of 2'-deoxyguanosine by a NO/O2 gas mixture : identification and characterization of N2-nitro-2'-deoxyguanosine"Org.Lett.. 5. 3173-3176 (2003)
Tajima, M.:“NO/O2 气体混合物对 2-脱氧鸟苷的硝化:N2-硝基-2-脱氧鸟苷的鉴定和表征”Org.Lett.. 5. 3173-3176 (2003)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tajima, K.: "Cu(II) and Zn(II) bound in the triple stranded α-helical coiled-coil activate water molecule : prototype for metalloenzyme"Peptide Synthesis. 1004(In press).
Tajima, K.:“Cu(II) 和 Zn(II) 结合在三链 α-螺旋卷曲螺旋活化水分子中:金属酶的原型”肽合成 1004(出版中)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: 10.1021/bi035419r
发表时间: 2004-05
期刊: Biochemistry
影响因子: 2.9
作者: [K. Kanaori;S. Sakamoto;H. Yoshida;P. Guga;W. Stec;K. Tajima;K. Makino]
通讯作者: K. Kanaori;S. Sakamoto;H. Yoshida;P. Guga;W. Stec;K. Tajima;K. Makino
14
    Application of a new HPLC-ESR system for water soluble components of foods and vegetables
    • 批准号:
      23580166
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.49万
    • 财政年份:
      2011
    • 负责人:
      TAJIMA Kunihiko
    • 依托单位:
    Mechanistic study for porpyrin metallation occurring in DNA-quartet structure
    • 批准号:
      11640563
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.3万
    • 财政年份:
      1999
    • 负责人:
      TAJIMA Kunihiko
    • 依托单位:
    Formation of Porphyrin-metal Complex Catalyzed by Single Strand DNA
    • 批准号:
      09640664
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.05万
    • 财政年份:
      1997
    • 负责人:
      TAJIMA Kunihiko
    • 依托单位:
    国内基金
    海外基金
    高等植物细胞色素b6f复合体血红素辅基Heme cn组装的分子机理研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      彭连伟
    • 依托单位:
    青蒿素类药物被heme激活后的代谢过程以及耐药疟原虫的代谢防御机制
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      52万元
    • 批准年份:
      2022
    • 负责人:
      邢杰
    • 依托单位:
    不依赖heme的脱羧酶undA的理性设计改造
    肉品中肌红蛋白Heme/Hemin辅基介导的肌球蛋白与水分子互作机制
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2021
    • 负责人:
    • 依托单位: